What is LOPJLB’s current signal on EWTX?

LOPJLB’s latest quantitative signal on Edgewise Therapeutics, Inc. (EWTX) is SELL in a BEAR regime. Signals are updated daily.

What market regime is EWTX in?

Edgewise Therapeutics, Inc. (EWTX) is currently classified in the BEAR HMM market regime on LOPJLB.

What does Edgewise Therapeutics, Inc. (EWTX) do?

Edgewise Therapeutics, Inc. is a biopharmaceutical firm dedicated to developing small-molecule treatments for a range of musculoskeletal disorders. Its leading investigational drug, EDG-5506, is an orally administered compound specifically engineered to tackle the fundamental genetic causes of dystrophinopathies, including Duchenne and Becker muscular dystrophy. This candidate has successfully …

Where is Edgewise Therapeutics, Inc. based / listed?

Edgewise Therapeutics, Inc. is based in US, listed on NASDAQ.

Edgewise Therapeutics, Inc. (EWTX)

COMPARE

Healthcare · Biotechnology · NASDAQ · US

$39.23-0.86%Close

SELLBEAR · day 7

RANGE

LOPJLB.COM

OHLCEMALEVELSSTOPFLIP52WSIGNALSBUYSELLEXHEXH ZONE

Key stats

Short interest · FINRA settlement 2026-09-15

Market cap: $4.2B
Beta: 0.28
P/E (TTM): -21.63

Short % float: 11.99%
Days to cover: 8.0
SI change: +2.1%

1W: -3.09%
1M: -9.59%

vs SPY 1W: -4.65%
vs SPY 1M: -11.35%

Industry peers

FMP comparable companies · ranked by market cap

PTCTSELLPTC Therapeutics, Inc.$5.3BRECOVERYQ 18$63.70-1.06%
DYNSELLDyne Therapeutics, Inc.$2.9BRECOVERYQ 3$15.40+2.50%
SRPTSELLSarepta Therapeutics, Inc.$1.8BRECOVERYQ 13$17.31+4.06%
STOKSELLStoke Therapeutics, Inc.$1.6BCRISISQ 10$24.37-1.40%
SLDBSELLSolid Biosciences Inc.$681MCRISISQ -13$6.92-0.44%

Prediction markets

Kalshi · Polymarket · … linked

Full prediction markets →

Loading markets…

Key stats

Industry peers

Prediction markets

Company news